Pancreatic Cancer Research

ResearcherNational Taiwan UniversityActive in the last 2 years

Y.M. Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5302-0433; OpenAlex author ID A5103167412. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 4

  1. Correction: SEMA7A-mediated juxtacrine stimulation of IGFBP-3 upregulates IL-17RB at pancreatic cancer invasive front. Co-author DOI 10.1038/s41417-024-00857-6↗
  2. SEMA7A-mediated juxtacrine stimulation of IGFBP-3 upregulates IL-17RB at pancreatic cancer invasive front. Co-author DOI 10.1038/s41417-024-00849-6↗
  3. Characterization of initial key steps of IL-17 receptor B oncogenic signaling for targeted therapy of pancreatic cancer. Co-author DOI 10.1126/scitranslmed.abc2823↗
  4. Cellular 5-hydroxylmethylcytosine content determines tumorigenic potential and prognosis of pancreatic ductal adenocarcinoma. Co-author PMID 30662811↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chun‐Mei Hu · 4 shared papers, 2018–2025 · strength 0.61
  2. Yu‐Ting Chang · 4 shared papers, 2018–2025 · strength 0.61
  3. Yu‐Wen Tien · 4 shared papers, 2018–2025 · strength 0.61
  4. Ming‐Chu Chang · 4 shared papers, 2018–2025 · strength 0.61
  5. Sui-Chih Tien · 2 shared papers, 2024–2025 · strength 0.42
  6. Hsuan‐Yu Peng · 2 shared papers, 2024–2025 · strength 0.42
  7. Yung‐Ming Jeng · 2 shared papers, 2018–2021 · strength 0.18
  8. Wen‐Hwa Lee · 2 shared papers, 2018–2021 · strength 0.18
  9. Lung‐Hung Tsai · 1 shared paper, 2021 · strength 0.11
  10. Heng‐Hsiung Wu · 1 shared paper, 2021 · strength 0.11
  11. Chia‐Ning Shen · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.